FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1980863823> ?p ?o ?g. }

• W1980863823 endingPage "37" @default.
• W1980863823 startingPage "37" @default.
• W1980863823 abstract "<h3>Background</h3> More than half of all individuals with bipolar disorder have a substance abuse problem at some point in their lifetime. Patients with comorbid substance abuse disorders often are excluded from clinical trials. Thus, treatments targeting this high-risk clinical population are lacking. <h3>Objective</h3> To evaluate the efficacy of divalproex sodium (hereafter referred to as valproate) in decreasing alcohol use and stabilizing mood symptoms in acutely ill patients with bipolar disorder and alcoholism. <h3>Design</h3> A 24-week, double-blind, placebo-controlled, randomized parallel-group trial. <h3>Setting</h3> A university hospital serving as a primary catchment-area hospital and tertiary-care facility. <h3>Participants</h3> Fifty-nine subjects with diagnoses of bipolar I disorder and alcohol dependence. <h3>Intervention</h3> All study subjects received treatment as usual, including lithium carbonate and psychosocial interventions, and were randomized to receive valproate or placebo. <h3>Main Outcome Measures</h3> Primary alcohol use outcomes included changes in alcohol use as indicated by changes in proportion of heavy drinking days and number of drinks per heavy drinking day. Other alcohol use outcomes included proportion of any drinking days, number of drinks per drinking day, and relapse to sustained heavy drinking. Mood outcomes included changes in depressive and manic symptoms. We used the mixed model to analyze longitudinal data. The first model used time of assessment, bipolar subtype (mixed, manic, or depressed), and treatment group (placebo or valproate) as covariates. The second nested model included the additional covariate of medication adherence. <h3>Results</h3> The valproate group had a significantly lower proportion of heavy drinking days (<i>P</i> = .02) and a trend toward fewer drinks per heavy drinking day (<i>P</i> = .055) than the placebo group. When medication adherence was added as covariate, the valproate group had significantly fewer drinks per heavy drinking day (<i>P</i> = .02) and fewer drinks per drinking day (<i>P</i> = .02). Higher valproate serum concentration significantly correlated with improved alcohol use outcomes. Manic and depressive symptoms improved equally in both groups. Level of γ-glutamyl transpeptidase was significantly higher in the placebo group compared with the valproate group. <h3>Conclusions</h3> Valproate therapy decreases heavy drinking in patients with comorbid bipolar disorder and alcohol dependence. The results of this study indicate the potential clinical utility of the anticonvulsant mood stabilizer, valproate, in bipolar disorder with co-occurring alcohol dependence." @default.
• W1980863823 created "2016-06-24" @default.
• W1980863823 creator A5006944675 @default.
• W1980863823 creator A5022933069 @default.
• W1980863823 creator A5045470354 @default.
• W1980863823 creator A5057756765 @default.
• W1980863823 creator A5084219920 @default.
• W1980863823 creator A5085107940 @default.
• W1980863823 date "2005-01-01" @default.
• W1980863823 modified "2023-10-16" @default.
• W1980863823 title "Efficacy of Valproate Maintenance in Patients With Bipolar Disorder and Alcoholism" @default.
• W1980863823 cites W133544837 @default.
• W1980863823 cites W140784171 @default.
• W1980863823 cites W1521535206 @default.
• W1980863823 cites W1560970226 @default.
• W1980863823 cites W179591728 @default.
• W1980863823 cites W1900097999 @default.
• W1980863823 cites W1970343218 @default.
• W1980863823 cites W1979282849 @default.
• W1980863823 cites W1996122356 @default.
• W1980863823 cites W2002476212 @default.
• W1980863823 cites W2007121124 @default.
• W1980863823 cites W2007316542 @default.
• W1980863823 cites W2009681445 @default.
• W1980863823 cites W2016052456 @default.
• W1980863823 cites W2021355104 @default.
• W1980863823 cites W2021874402 @default.
• W1980863823 cites W2024374498 @default.
• W1980863823 cites W2027560794 @default.
• W1980863823 cites W2027656344 @default.
• W1980863823 cites W2029305411 @default.
• W1980863823 cites W2031463262 @default.
• W1980863823 cites W2047442007 @default.
• W1980863823 cites W2051446251 @default.
• W1980863823 cites W2054572750 @default.
• W1980863823 cites W2058392863 @default.
• W1980863823 cites W2064279221 @default.
• W1980863823 cites W2065399671 @default.
• W1980863823 cites W2066627514 @default.
• W1980863823 cites W2072283508 @default.
• W1980863823 cites W2074114286 @default.
• W1980863823 cites W2080372328 @default.
• W1980863823 cites W2090592059 @default.
• W1980863823 cites W2099676946 @default.
• W1980863823 cites W2102658965 @default.
• W1980863823 cites W2108035829 @default.
• W1980863823 cites W2108740579 @default.
• W1980863823 cites W2111426309 @default.
• W1980863823 cites W2112780084 @default.
• W1980863823 cites W2115610172 @default.
• W1980863823 cites W2116476169 @default.
• W1980863823 cites W2117556837 @default.
• W1980863823 cites W2119226169 @default.
• W1980863823 cites W2121339106 @default.
• W1980863823 cites W2122195069 @default.
• W1980863823 cites W2123282949 @default.
• W1980863823 cites W2124876944 @default.
• W1980863823 cites W2128309600 @default.
• W1980863823 cites W2130040176 @default.
• W1980863823 cites W2136720775 @default.
• W1980863823 cites W2139031901 @default.
• W1980863823 cites W2143438415 @default.
• W1980863823 cites W2145778815 @default.
• W1980863823 cites W2162337181 @default.
• W1980863823 cites W2167896264 @default.
• W1980863823 cites W2323757316 @default.
• W1980863823 cites W2411224250 @default.
• W1980863823 cites W2418454560 @default.
• W1980863823 cites W2735928575 @default.
• W1980863823 cites W3026523878 @default.
• W1980863823 cites W3217490374 @default.
• W1980863823 cites W44083706 @default.
• W1980863823 cites W69017033 @default.
• W1980863823 cites W2060711552 @default.
• W1980863823 doi "https://doi.org/10.1001/archpsyc.62.1.37" @default.
• W1980863823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15630071" @default.
• W1980863823 hasPublicationYear "2005" @default.
• W1980863823 type Work @default.
• W1980863823 sameAs 1980863823 @default.
• W1980863823 citedByCount "236" @default.
• W1980863823 countsByYear W19808638232012 @default.
• W1980863823 countsByYear W19808638232013 @default.
• W1980863823 countsByYear W19808638232014 @default.
• W1980863823 countsByYear W19808638232015 @default.
• W1980863823 countsByYear W19808638232016 @default.
• W1980863823 countsByYear W19808638232017 @default.
• W1980863823 countsByYear W19808638232018 @default.
• W1980863823 countsByYear W19808638232019 @default.
• W1980863823 countsByYear W19808638232020 @default.
• W1980863823 countsByYear W19808638232021 @default.
• W1980863823 countsByYear W19808638232022 @default.
• W1980863823 countsByYear W19808638232023 @default.
• W1980863823 crossrefType "journal-article" @default.
• W1980863823 hasAuthorship W1980863823A5006944675 @default.
• W1980863823 hasAuthorship W1980863823A5022933069 @default.
• W1980863823 hasAuthorship W1980863823A5045470354 @default.
• W1980863823 hasAuthorship W1980863823A5057756765 @default.
• W1980863823 hasAuthorship W1980863823A5084219920 @default.

• next